Sanofi weighs M&A opportunities to replenish pipeline, lifts 2026 growth targets

By Bhanvi Satija LONDON, Oct 30 (Reuters) – French drugmaker Sanofi said on Friday that dealmaking will be an important part of replenishing the company's drug pipeline under new CEO Belen Garijo,

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)